163 related articles for article (PubMed ID: 21843508)
1. Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency.
Flück CE; Mallet D; Hofer G; Samara-Boustani D; Leger J; Polak M; Morel Y; Pandey AV
Biochem Biophys Res Commun; 2011 Sep; 412(4):572-7. PubMed ID: 21843508
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.
Dhir V; Ivison HE; Krone N; Shackleton CH; Doherty AJ; Stewart PM; Arlt W
Mol Endocrinol; 2007 Aug; 21(8):1958-68. PubMed ID: 17505056
[TBL] [Abstract][Full Text] [Related]
3. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical consequences of p450 oxidoreductase deficiency.
Flück CE; Pandey AV
Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.
Pandey AV; Kempná P; Hofer G; Mullis PE; Flück CE
Mol Endocrinol; 2007 Oct; 21(10):2579-95. PubMed ID: 17595315
[TBL] [Abstract][Full Text] [Related]
6. P450 Oxidoreductase Deficiency: Loss of Activity Caused by Protein Instability From a Novel L374H Mutation.
Parween S; Roucher-Boulez F; Flück CE; Lienhardt-Roussie A; Mallet D; Morel Y; Pandey AV
J Clin Endocrinol Metab; 2016 Dec; 101(12):4789-4798. PubMed ID: 27603900
[TBL] [Abstract][Full Text] [Related]
7. Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype.
Parween S; Fernández-Cancio M; Benito-Sanz S; Camats N; Rojas Velazquez MN; López-Siguero JP; Udhane SS; Kagawa N; Flück CE; Audí L; Pandey AV
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32060549
[TBL] [Abstract][Full Text] [Related]
8. Genetics of congenital adrenal hyperplasia.
Krone N; Arlt W
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):181-92. PubMed ID: 19500762
[TBL] [Abstract][Full Text] [Related]
9. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
[TBL] [Abstract][Full Text] [Related]
10. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
Sahakitrungruang T; Huang N; Tee MK; Agrawal V; Russell WE; Crock P; Murphy N; Migeon CJ; Miller WL
J Clin Endocrinol Metab; 2009 Dec; 94(12):4992-5000. PubMed ID: 19837910
[TBL] [Abstract][Full Text] [Related]
11. Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.
Aljabri A; Alnaim F; Alsaleh Y
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994263
[TBL] [Abstract][Full Text] [Related]
12. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations.
Miller WL
Trends Endocrinol Metab; 2004 Sep; 15(7):311-5. PubMed ID: 15350602
[TBL] [Abstract][Full Text] [Related]
13. Impact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase.
Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):64-70. PubMed ID: 27032764
[TBL] [Abstract][Full Text] [Related]
14. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical features of p450 oxidoreductase deficiency.
Scott RR; Miller WL
Horm Res; 2008; 69(5):266-75. PubMed ID: 18259105
[TBL] [Abstract][Full Text] [Related]
16. NADPH P450 oxidoreductase: structure, function, and pathology of diseases.
Pandey AV; Flück CE
Pharmacol Ther; 2013 May; 138(2):229-54. PubMed ID: 23353702
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
[TBL] [Abstract][Full Text] [Related]
18. Organization of cytochrome P450 enzymes involved in sex steroid synthesis: PROTEIN-PROTEIN INTERACTIONS IN LIPID MEMBRANES.
Praporski S; Ng SM; Nguyen AD; Corbin CJ; Mechler A; Zheng J; Conley AJ; Martin LL
J Biol Chem; 2009 Nov; 284(48):33224-32. PubMed ID: 19805543
[TBL] [Abstract][Full Text] [Related]
19. SPR-Based study of affinity of cytochrome P450s / redox partners interactions modulated by steroidal substrates.
Ershov PV; Yablokov ЕO; Florinskaya AV; Mezentsev YV; Kaluzhskiy LА; Tumilovich AM; Gilep АА; Usanov SA; Ivanov АS
J Steroid Biochem Mol Biol; 2019 Mar; 187():124-129. PubMed ID: 30468857
[TBL] [Abstract][Full Text] [Related]
20. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.
Homma K; Hasegawa T; Nagai T; Adachi M; Horikawa R; Fujiwara I; Tajima T; Takeda R; Fukami M; Ogata T
J Clin Endocrinol Metab; 2006 Jul; 91(7):2643-9. PubMed ID: 16608896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
